Works by Horiguchi, Jun


Results: 156
    1

    Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.

    Published in:
    2017
    By:
    • Sasagu Kurozumi;
    • Hiroshi Matsumoto;
    • Yuji Hayashi;
    • Katsunori Tozuka;
    • Kenichi Inoue;
    • Jun Horiguchi;
    • Izumi Takeyoshi;
    • Tetsunari Oyama;
    • Masafumi Kurosumi;
    • Kurozumi, Sasagu;
    • Matsumoto, Hiroshi;
    • Hayashi, Yuji;
    • Tozuka, Katsunori;
    • Inoue, Kenichi;
    • Horiguchi, Jun;
    • Takeyoshi, Izumi;
    • Oyama, Tetsunari;
    • Kurosumi, Masafumi
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9

    BREATH-HOLDING SPELLS IN SOMATOFORM DISORDER.

    Published in:
    International Journal of Psychiatry in Medicine, 2004, v. 34, n. 2, p. 201, doi. 10.2190/T6L4-Y24N-DLTM-APH2
    By:
    • Inagaki, Takuji;
    • Mizuno, Soichi;
    • Miyaoka, Tsuyoshi;
    • Tsubouchi, Ken;
    • Momose, Isamu;
    • Kishi, Toshiro;
    • Horiguchi, Jun;
    • Kanata, Kazue;
    • Hiruta, Hiroyuki;
    • Nakatani, Toshihiko;
    • Doi, Katsushi;
    • Saito, Yoji
    Publication type:
    Article
    10
    11
    12
    13

    Late-onset schizophrenia with epileptiform discharge.

    Published in:
    International Journal of Psychiatry in Clinical Practice, 2001, v. 5, n. 1, p. 67, doi. 10.1080/136515001300225222
    By:
    • Miyaoka, Tsuyoshi;
    • Seno, Haruo;
    • Yamamori, Chikako;
    • Iijima, Masaaki;
    • Inagaki, Takuji;
    • Horiguchi, Jun
    Publication type:
    Article
    14
    15
    16

    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.

    Published in:
    PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201846
    By:
    • Kurozumi, Sasagu;
    • Matsumoto, Hiroshi;
    • Inoue, Kenichi;
    • Tozuka, Katsunori;
    • Hayashi, Yuji;
    • Kurosumi, Masafumi;
    • Oyama, Tetsunari;
    • Fujii, Takaaki;
    • Horiguchi, Jun;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    17
    18
    19
    20
    21

    Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06615-8
    By:
    • Kurozumi, Sasagu;
    • Kaira, Kyoichi;
    • Matsumoto, Hiroshi;
    • Kurosumi, Masafumi;
    • Yokobori, Takehiko;
    • Kanai, Yoshikatsu;
    • Sekine, Chikako;
    • Honda, Chikako;
    • Katayama, Ayaka;
    • Furuya, Mio;
    • Shiino, Sho;
    • Makiguchi, Takaya;
    • Mongan, Nigel P.;
    • Rakha, Emad A.;
    • Oyama, Tetsunari;
    • Fujii, Takaaki;
    • Shirabe, Ken;
    • Horiguchi, Jun
    Publication type:
    Article
    22
    23
    24
    25
    26

    2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 1, p. 1, doi. 10.1007/s12282-014-0550-2
    By:
    • Mukai, Hirofumi;
    • Noguchi, Shinzaburo;
    • Akiyama, Futoshi;
    • Inaji, Hideo;
    • Iwase, Hirotaka;
    • Horiguchi, Jun;
    • Kurebayashi, Junichi;
    • Hirata, Koichi;
    • Toi, Masakazu;
    • Kurosumi, Masafumi;
    • Kohno, Norio;
    • Nishimura, Reiki;
    • Nakamura, Seigo;
    • Imoto, Shigeru;
    • Iwase, Takuji;
    • Endo, Tokiko;
    • Saeki, Toshiaki;
    • Ogawa, Yasuhiro;
    • Ito, Yoshinori;
    • Tokuda, Yutaka
    Publication type:
    Article
    27

    Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

    Published in:
    Breast Cancer (13406868), 2014, v. 21, n. 6, p. 703, doi. 10.1007/s12282-013-0444-8
    By:
    • Noguchi, Shinzaburo;
    • Masuda, Norikazu;
    • Iwata, Hiroji;
    • Mukai, Hirofumi;
    • Horiguchi, Jun;
    • Puttawibul, Puttisak;
    • Srimuninnimit, Vichien;
    • Tokuda, Yutaka;
    • Kuroi, Katsumasa;
    • Iwase, Hirotaka;
    • Inaji, Hideo;
    • Ohsumi, Shozo;
    • Noh, Woo-Chul;
    • Nakayama, Takahiro;
    • Ohno, Shinji;
    • Rai, Yoshiaki;
    • Park, Byeong-Woo;
    • Panneerselvam, Ashok;
    • El-Hashimy, Mona;
    • Taran, Tetiana
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    ER, PgR, Ki67, p27<sup>Kip1</sup>, and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1641-y
    By:
    • Sasagu Kurozumi;
    • Kenichi Inoue;
    • Hiroyuki Takei;
    • Hiroshi Matsumoto;
    • Masafumi Kurosumi;
    • Jun Horiguchi;
    • Izumi Takeyoshi;
    • Tetsunari Oyama
    Publication type:
    Article
    45
    46
    47
    48
    49
    50